Centocor Loses Bid To Dismiss Remicade Suit
Johnson & Johnson Inc. subsidiary Centocor Ortho Biotech Inc. has failed to persuade a federal judge to throw out a suit a patient filed over a warning label developed for Remicade....To view the full article, register now.
Already a subscriber? Click here to view full article